retatrutide triple hormone receptor agonist retatrutide Side Effects: What Patients Should Know Retatrutide, an investigational triple hormone

It is a cathelicidin peptide, which means it belongs to a family of peptid...

B-cell depletion with obinutuzumab for the treatment of proliferative lupus nephritis: a randomised, double-blind, placebo-controlled trial

Global incidence, prevalence, and mortality of type 1 diabetes in 2021 with projection to 2040: s modelling study

Unlike a regular facial or beauty treatment, clinical glow therapies target the actual biological causes of dull, uneven or tired-looking skin working at the dermal and sub-dermal level using medical-grade technology to produce genuine, measurable luminosity

Exendin-4, a glucagon-like peptide-1 receptor agonist, reduces Alzheimer disease-associated tau hyperphosphorylation in the hippocampus of rats with type 2 diabetes